 |
市場調査レポート
商品コード
1463477
神経血管カテーテルの世界市場規模、シェア、成長分析、用途別、タイプ別 - 産業予測、2024～2031年Global Neurovascular Catheters Market Size, Share, Growth Analysis, By Application(Embolic Stroke, Brain Aneurysms), By Type(Micro, Balloon) - Industry Forecast 2024-2031 |
||||||
| 神経血管カテーテルの世界市場規模、シェア、成長分析、用途別、タイプ別 - 産業予測、2024～2031年 |
|
出版日: 2024年04月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の神経血管カテーテルの市場規模は、2022年に30億3,000万米ドルとなり、予測期間（2024～2031年）のCAGRは7.20%で、2023年の32億5,000万米ドルから、2031年までに56億6,000万米ドルに成長する見通しです。
神経血管市場は、脳動脈瘤や脳卒中などの神経疾患の罹患率の上昇、不健康なライフスタイルの定着、神経疾患治療に対する一般市民の意識の高まり、可処分所得の増加、大手市場参入企業による新製品導入など、いくつかの重要な促進要因によって支えられています。神経血管カテーテル技術の進歩に伴う神経血管疾患の急増は、市場拡大に拍車をかける構えです。特に、くも膜下出血（SAH）の世界有病率は10万人当たり6.67人で、毎年50万人以上が罹患しており、低・中所得国が大きな負担を負っています。さらに、神経血管アクセスカテーテルの技術革新により、市場の成長は持続すると予想されます。例えば、2022年2月、Johnson & Johnson Medical Device Companiesの子会社であるCERENOVUSは、急性虚血性脳卒中インターベンションを含む血管内処置用の最先端バルーンガイドカテーテルであるEMBOGUARDを発売しました。2022年9月には、大腿動脈と橈骨動脈の両方を経由する神経血管治療における内径0.096インチのアクセスカテーテルの有効性を強調する調査が行われ、高い技術的成功率と最小限の手技合併症が実証されました。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要な投資の分析
- 主要な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
神経血管カテーテルの世界市場：用途別
- 市場概要
- 塞栓性脳卒中
- 脳動脈瘤
- 動静脈奇形
- その他
神経血管カテーテルの世界市場：タイプ別
- 市場概要
- マイクロ
- バルーン
- アクセス
- 塞栓術
- その他
神経血管カテーテルの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic plc（Ireland）
- Stryker Corporation（US）
- Terumo Corporation（Japan）
- Penumbra, Inc.（US）
- MicroPort Scientific Corporation（China）
- Johnson & Johnson（US）
- Merit Medical Systems, Inc.（US）
- Integer Holdings Corporation（US）
- Teleflex Incorporated（US）
- Penumbra, Inc.（US）
- Rapid Medical Ltd.（Israel）
- MicroVention, Inc.（US）
- Acandis GmbH（Germany）
- Balt Extrusion（France）
- Covidien（US）
- Boston Scientific Corporation（US）
- Cook Medical LLC（US）
- Phenox GmbH（Germany）
- Stryker Neurovascular（US）
- Balt USA LLC（US）
- Metactive Medical, Inc.（US）
- Amplitude Surgical SA（France）
Global Neurovascular Catheters Market size was valued at USD 3.03 Billion in 2022 and is poised to grow from USD 3.25 Billion in 2023 to USD 5.66 Billion by 2031, at a CAGR of 7.20% during the forecast period (2024-2031).
Several significant drivers propel the neurovascular market, including the escalating incidence of neurological disorders like brain aneurysms and stroke, the uptake of unhealthy lifestyles, heightened public consciousness regarding neurological ailment treatment, increasing disposable income, and the introduction of novel products by major market players. The surge in neurovascular diseases alongside advancements in neurovascular catheter technology are poised to fuel market expansion. Notably, the global prevalence of subarachnoid hemorrhage (SAH) stands at 6.67 per 100,000 individuals, affecting over 500,000 people annually, with low- and middle-income countries bearing a substantial burden. Furthermore, market growth is expected to persist due to technological breakthroughs in neurovascular access catheters. For instance, in February 2022, CERENOVUS, a subsidiary of Johnson & Johnson Medical Device Companies, launched EMBOGUARD, a cutting-edge balloon guide catheter for endovascular procedures, including acute ischemic stroke interventions. The market is likely to expand further with ongoing research and comparative studies on different neurovascular access catheters, such as the study in September 2022 highlighting the efficacy of access catheters with an inner diameter of 0.096 inches for neurovascular therapies via both femoral and radial arteries, demonstrating high technical success rates and minimal procedural complications.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurovascular Catheters Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Neurovascular Catheters Market Segmental Analysis
Global Neurovascular Catheters Market is segmented on the basis of application, type, end use and region. By type, the market is segmented into micro, balloon, access, embolization, and others. By application, the market is segmented into embolic stroke, brain aneurysms, arteriovenous malformations, and others. By end use, the market is segmented into hospitals, clinics, ambulatory surgical centers, and diagnostic centers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Neurovascular Catheters Market
The increasing incidence of neurological conditions like stroke, aneurysms, and arteriovenous malformations (AVMs) is fueling the need for neurovascular catheters, which are crucial for both diagnosis and treatment. As the occurrence of these disorders continues to rise, the demand for neurovascular catheters is also escalating accordingly.
Restraints in the Global Neurovascular Catheters Market
Neurovascular catheters are employed for accessing and maneuvering through intricate blood vessels within the brain, presenting challenges that may result in diverse complications including bleeding, clotting, vessel perforation, and infection. These complications pose significant risks, potentially leading to severe neurological impairments or fatality, and contribute to prolonged hospitalization and escalated healthcare expenses. Furthermore, the likelihood of complications is heightened in patients with concurrent medical conditions.
Market Trends of the Global Neurovascular Catheters Market
The rising occurrence of neurological conditions like stroke, aneurysms, and arteriovenous malformations is fueling the need for neurovascular catheters. As per the World Health Organization (WHO), stroke ranks as the second most prevalent cause of death worldwide, intensifying the demand for viable treatment solutions for neurological disorders.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Neurovascular Catheters Market by Application
- Market Overview
- Embolic Stroke
- Brain Aneurysms
- Arteriovenous Malformations
- Others
Global Neurovascular Catheters Market by Type
- Market Overview
- Micro
- Balloon
- Access
- Embolization
- Others
Global Neurovascular Catheters Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integer Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rapid Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroVention, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Acandis GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Balt Extrusion (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Covidien (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Phenox GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Neurovascular (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Balt USA LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Metactive Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amplitude Surgical SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
